中华眼底病杂志

中华眼底病杂志

光相干断层扫描联合微视野检查在糖尿病黄斑水肿中的应用研究进展

查看全文

糖尿病黄斑水肿(DME)是非增生期糖尿病视网膜病变患者视力损害的主要原因。光相干断层扫描(OCT)可以检测DME患者视网膜各层厚度,发现视网膜层间的病理改变。微视野检查可以定性、定量地获得受检者视网膜特定位置的光敏感度,同时分析固视状态。通过OCT可以进一步观察DME视网膜的病理性解剖结构改变,并可根据相应微视野检查结果理解结构改变和功能下降的相应关系。目前针对于DME患者的治疗方式多样,主要疗效评估方式是通过OCT观察治疗前后视网膜病理改变是否改善、消失,联合微视野检查还可以获知接受治疗后患者视功能的恢复情况。联合应用OCT和微视野检查,在DME患者的诊断、治疗方面有着广泛的应用前景。

Diabetic macular edema is the major cause of vision impairment in patients with non-proliferative diabetic retinopathy. Thickness and pathological alterations in each retina layer of diabetic macular edema (DME) patients can be performed by optical coherence tomography (OCT) device. And retinal light sensitivity at specific retinal point and fixation state can be detected by microperimetry qualitatively and quantitatively. Moreover, OCT can discover pathological anatomical changes in the retina of DME patients, thus facilitating the interpretation of the structure-function relationship in DME with combination of microperimetry results. At present, there are various therapies for DME patients, and the primary method in evaluating therapeutic efficacy is to compare the pathological changes in the retina before and after treatment by OCT. Besides, microperimetry can provide information in visual function restoration. The combined application of OCT and microperimetry has broad prospects in the diagnosis and treatment of DME patients.

关键词: 体层摄影术,光学相干; 视野测试; 黄斑水肿; 糖尿病视网膜病变/并发症; 综述

Key words: Tomography, optical coherence; Visual field test; Macular edema; Diabetic retinopathy/complications; Review

引用本文: 王韫智, 郑志. 光相干断层扫描联合微视野检查在糖尿病黄斑水肿中的应用研究进展. 中华眼底病杂志, 2018, 34(4): 404-407. doi: 10.3760/cma.j.issn.1005-1015.2018.04.023 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Markowitz Samuel N, Reyes Sophia V. Microperimetry and clinical practice: an evidence-based review[J]. Can J of Ophthalmol, 2013, 48(5): 350-357. DOI: 10.1016/j.jcjo.2012.03.004.
2. Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR, et al. Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema[J]. Ophthalmology, 2007, 114(3): 525-536. DOI: 10.1016/j.ophtha.2006.06.052.
3. Okada K, Yamamoto S, Mizunoya S, et al. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema[J]. Eye, 2006, 20(7): 805. DOI: 10.1038/sj.eye.6702014.
4. Hatef E, Colantuoni E, Wang J, et al. The relationship between macular sensitivity and retinal thickness in eyes with diabetic macular edema[J]. Am J Ophthalmol, 2011, 152(3): 400-405. DOI: 10.1016/j.ajo.2011.02.024.
5. Vujosevic S, Midena E, Pilotto E, et al. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings[J]. Invest Ophthalmol Vis Sci, 2006, 47(7): 3044-3051. DOI: 10.1167/iovs.05-1141.
6. Carpineto P, Ciancaglini M, Di Antonio L, et al. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema[J]. Retina, 2007, 27(1): 21-29. DOI: 10.1097/01.iae.0000256658.71864.ca.
7. 杨晓璐, 邹海东, 许迅, 等.不同类型糖尿病黄斑水肿患者视网膜敏感度和视力与黄斑厚度相关性分析[J]. 中华眼科杂志, 2013, 49(12): 1081-1088. DOI: 10.3760/cma.j.issn.0412-4081.2013.12.006.Yang XL, Zou HD, Xu X, et al. Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema[J]. Chin J Ophthalmol, 2013, 49(12): 1081-1088. DOI: 10.3760/cma.j.issn.0412-4081.2013.12.006.
8. Deák GG, Bolz M, Ritter M, et al. A systematic correlation between morphology and functional alterations in diabetic macular edema[J]. Invest Ophthalmol Vis Sci, 2010, 51(12): 6710-6714. DOI: 10.1167/iovs.09-5064.
9. Soliman W, Hasler P, Sander B, et al. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema[J]. Acta Ophthalmol, 2012, 90(3): 248-253. DOI: 10.1111/j.1755-3768.2010.01912.x.
10. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography[J]. Am J Ophthalmol, 1999, 127(6): 688-693. DOI: https://doi.org/10.1016/S0002-9394(99)00033-1.
11. Forte R, Cennamo G, Finelli ML, et al. Retinal micropseudocysts in diabetic retinopathy: prospective functional and anatomic evaluation[J]. Ophthalmic Res, 2012, 48(1): 6-11. DOI: 10.1159/000334618.
12. Kothari AR, Raman RPG, Sharma T, et al. Is there a correlation between structural alterations and retinal sensitivity in morphological patterns of diabetic macular edema?[J]. Indian J Ophthalmol, 2013, 61(5): 230-232. DOI: 10.4103/0301-4738.97081.
13. Velaga SB, Nittala MG, Parinitha B, et al. Correlation between retinal sensitivity and cystoid space characteristics in diabetic macular edema[J]. Indian J Ophthalmol, 2016, 64(6): 452-458. DOI: 10.4103/0301-4738.187675.
14. Raman R, Nittala MG, Gella L, et al. Retinal sensitivity over hard exudates in diabetic retinopathy[J]. J Ophthalmic Vis Res, 2015, 10(2): 160-164. DOI: 10.4103/2008-322X.163771.
15. Vujosevic S, Pilotto E, Bottega E, et al. Retinal fixation impairment in diabetic macular edema[J]. Retina, 2008, 28(10): 1443-1450. DOI: 10.1097/IAE.0b013e318183571e.
16. Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in diabetic cystoid macular oedema[J]. Acta Ophthalmol Scand, 2005, 83(1): 63-66. DOI: 10.1111/j.1600-0420.2005.00387.x.
17. Gaucher D, Sebah C, Erginay A, et al. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema[J]. Am J Ophthalmol, 2008, 145(2): 289-296. DOI: 10.1016/j.ajo.2007.09.029.
18. Shen Y, Liu K, Xu X. Correlation between visual function and photoreceptor integrity in diabetic macular edema: spectral-domain optical coherence tomography[J]. Curr Eye Res, 2016, 41(3): 391-399. DOI: 10.3109/02713683.2015.1019003.
19. Vujosevic S, Torresin T, Berton M, et al. Diabetic macular edema with and without subfoveal neuroretinal detachment: two different morphologic and functional entities[J]. Am J Ophthalmol, 2017, 181: 149-155. DOI: 10.1016/j.ajo.2017.06.026.
20. Rajiv R, Kiruthika S, Laxmi G, et al. Morphological and functional outcomes following modified early treatment diabetic retinopathy study laser in diabetic macular edema[J]. Oman J Ophthalmol, 2015, 8(2): 92-96. DOI: 10.4103/0974-620X.159252.
21. Reznicek L, Cserhati S, Seidensticker F, et al. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment[J]. Acta Ophthalmol, 2013, 91(7): 529-536. DOI: 10.1111/aos.12153.
22. Malagola R, Spinucci G, Cofone C, et al. Prospective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edema[J]. Int Ophthalmol, 2013, 33(3): 261-267. DOI: 10.1007/s10792-012-9685-3.
23. Vujosevic S, Berton M, Bini S, et al. Hyperreflective retinal spots and visual function after anti-vascular endothelial growth factor treatment in center-involving diabetic macular edema[J]. Retina, 2016, 36(7): 1298-1308. DOI: 10.1097/IAE.0000000000000912.
24. Karacorlu M, Ozdemir H, Senturk F, et al. Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema[J]. Acta Ophthalmol, 2010, 88(5): 558-563. DOI: 10.1111/j.1755-3768.2008.01497.x.
25. Grenga P, Lupo S, Domanico D, et al. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study[J]. Retina, 2008, 28(9): 1270-1275. DOI: 10.1097/IAE.0b013e31817d5d1c.
26. Vujosevic S, Torresin T, Bini S, et al. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema[J]. Acta ophthalmol, 2017, 95(5): 464-471. DOI: 10.1111/aos.13294.